GENEVA, Oct. 20 -- VYRIAD (2900 37th Street NW, Building 110Rochester, Minnesota 55901) filed a patent application (PCT/US2025/024301) for "RECOMBINANT RHABDOVIRAL G GLYCOPROTEINS AND USES THEREOF" on Apr 11, 2025. With publication no. WO/2025/217533, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOY, Melissa (c/o Vyriad, 2900 37th Street NW, Building 110Rochester, 55901), KANAKALA, Surapathrudu (c/o Vyriad, 2900 37th Street NW, Building 110Rochester, Minnesota 55901), PACKIRISWAMY, Nandakumar (c/o Vyriad, 2900 37th Str...